Boehringer Ingelheim Pharmaceuticals, Inc.Usage: GLYXAMBI (empagliflozin/linagliptin) is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Empagliflozin also reduces the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.